John A. Howe
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Virology top 5%
- HIV Research and Treatment
Papers in
- Hepatology 17
- Hepatitis C virus research 17
-
- HIV/AIDS drug development and treatment 5
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- S. T. Bayley (3 shared papers)Stanley T. Bayley (3 shared papers)Cay Egan (2 shared papers)Philip E. Branton (2 shared papers)Joe S. Mymryk (3 shared papers)Tony N. Jelsma (3 shared papers)John W. Newport (1 shared paper)B Ferguson (1 shared paper)
- Journals
- Virology (8 papers)Journal of Hepatology (6 papers)ACS Medicinal Chemistry Letters (3 papers)Cancer Gene Therapy (2 papers)Open Forum Infectious Diseases (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
John A. Howe
49 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 78
- Hepatology 282
- Virology 130
- Oncology 434
- Genetics 492
- Molecular Biology 903
Countries citing papers authored by John A. Howe
This map shows the geographic impact of John A. Howe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Howe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Howe more than expected).
Fields of papers citing papers by John A. Howe
This network shows the impact of papers produced by John A. Howe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Howe. The network helps show where John A. Howe may publish in the future.
Co-authors
The 25 scholars most cited alongside John A. Howe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 331 | |
| 2 | 1988 | 200 | |
| 3 | 1990 | 181 | |
| 4 | 1989 | 136 | |
| 5 | 2001 | 124 | |
| 6 | 2018 | 88 | |
| 7 | 1992 | 86 | |
| 8 | 1996 | 85 | |
| 9 | 2017 | 82 | |
| 10 | 1988 | 79 | |
| 11 | 2008 | 77 | |
| 12 | 2013 | 60 | |
| 13 | 2016 | 59 | |
| 14 | 2012 | 56 | |
| 15 | Adenoviral-mediated expression of a kinase-dead mutant of Akt induces apoptosis selectively in tumor cells and suppresses tumor growth in mice. | 2003 | 46 |
| 16 | 2008 | 46 | |
| 17 | 2010 | 39 | |
| 18 | 2013 | 36 | |
| 19 | 2001 | 33 | |
| 20 | 2023 | 33 |
About John A. Howe
John A. Howe is a scholar working on Hepatology, Infectious Diseases, Virology, Genetics and Oncology, having authored 50 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (17 papers), Virus-based gene therapy research (10 papers), RNA and protein synthesis mechanisms (5 papers), HIV Research and Treatment (5 papers), Cancer-related Molecular Pathways (5 papers), HIV/AIDS drug development and treatment (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Respiratory viral infections research (3 papers). The work is most often cited by research in Hepatology (282 citations), Virology (130 citations), Oncology (434 citations), Genetics (492 citations) and Molecular Biology (903 citations). John A. Howe has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include S. T. Bayley, Stanley T. Bayley, Cay Egan, Philip E. Branton, Joe S. Mymryk, Tony N. Jelsma, John W. Newport, B Ferguson, Carole M. Evelegh and Robert A. Ogert. Their work appears in journals such as Virology, Journal of Hepatology, ACS Medicinal Chemistry Letters, Cancer Gene Therapy and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.